Cel-Sci/$CVM
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Cel-Sci
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
Ticker
$CVM
Sector
Primary listing
AMEX
Employees
44
Headquarters
Website
Cel-Sci Metrics
BasicAdvanced
$42M
-
-$6.27
-
-
Price and volume
Market cap
$42M
52-week high
$13.48
52-week low
$1.98
Average daily volume
68K
Financial strength
Current ratio
2.26
Quick ratio
2.136
Long term debt to equity
43.511
Total debt to equity
58.807
Interest coverage (TTM)
-38.23%
Profitability
EBITDA (TTM)
-20.925
Management effectiveness
Return on assets (TTM)
-56.23%
Return on equity (TTM)
-176.32%
Valuation
Price to book
2.63
Price to tangible book (TTM)
2.65
Price to free cash flow (TTM)
-1.236
Free cash flow yield (TTM)
-80.89%
Free cash flow per share (TTM)
-4.231
Growth
Earnings per share change (TTM)
-59.05%
3-year earnings per share growth (CAGR)
-37.89%
10-year earnings per share growth (CAGR)
-32.42%
Cel-Sci News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cel-Sci stock?
Cel-Sci (CVM) has a market cap of $42M as of December 31, 2025.
What is the P/E ratio for Cel-Sci stock?
The price to earnings (P/E) ratio for Cel-Sci (CVM) stock is 0 as of December 31, 2025.
Does Cel-Sci stock pay dividends?
No, Cel-Sci (CVM) stock does not pay dividends to its shareholders as of December 31, 2025.
When is the next Cel-Sci dividend payment date?
Cel-Sci (CVM) stock does not pay dividends to its shareholders.
What is the beta indicator for Cel-Sci?
Cel-Sci (CVM) does not currently have a Beta indicator.